The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Amlodipine And Olmesartan Medoxomil
Amlodipine and Olmesartan Medoxomil · AMLODIPINE BESYLATE 10 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 · Tablet · Oral · Micro Labs Limited
NDC 42571-0238-05 · 500 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for amlodipine and olmesartan medoxomil (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market · 2 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Micro Labs LimitedIndiaanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA207435
- TE code
- AB
- Approval date
- Nov 2, 2017
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Amlodipine and Olmesartan Medoxomil (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Ascend Laboratories, LLC | AMLODIPINE BESYLATE 10 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ascend Laboratories, LLC | AMLODIPINE BESYLATE 10 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ascend Laboratories, LLC | AMLODIPINE BESYLATE 5 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ascend Laboratories, LLC | AMLODIPINE BESYLATE 5 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | AMLODIPINE BESYLATE 5 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Micro Labs Limited | AMLODIPINE BESYLATE 5 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Micro Labs Limited | AMLODIPINE BESYLATE 10 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Micro Labs Limited | AMLODIPINE BESYLATE 5 mg/1; OLMESARTAN MEDOXOMIL 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Micro Labs Limited | AMLODIPINE BESYLATE 10 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Amlodipine And Olmesartan Medoxomil — NDC 42571-0238-05," retrieved September 3, 2026, https://drugdashboards.com/drug/42571023805.
Free to cite with attribution — see how the data is put together.